The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has agreed on a direct healthcare professional communication to alert practitioners to a small increased ...
A comprehensive new review led by Mayo Clinic is helping shape how clinicians diagnose and treat meningioma, the most common primary brain tumor, with a focus on personalized, patient-centered care ...
A comprehensive new review led by Mayo Clinic is helping shape how clinicians diagnose and treat meningioma, the most common primary brain tumor, with a focus on personalized, patient-centered care ...
VACCINATION RATE, THE RISK TO THE PUBLIC IS LOW. IN TONIGHT’S WOMAN’S DOCTOR, WE GET THE FACTS ON MENINGIOMA. IT’S A TUMOR INSIDE YOUR HEAD. THEY’RE USUALLY BENIGN, BUT AS OUR LACEE GRIFFITH EXPLAINS, ...
Sean is a JDM and off-road enthusiast of many years, and an automotive photographer. He holds a B.A. in Literature and Writing Studies, an A.A. in Communications, and an A.A. in English. He is ...
Findings from a phase 2 study demonstrate the feasibility of conducting genomically driven trials among patients with meningiomas. Abemaciclib (Verzenio) demonstrated clinical activity in patients ...
For some women, pregnancy is a time of profound loss. Not all pregnancies progress as expected. One serious complication is ectopic pregnancy, a condition in which a fertilised egg implants somewhere ...
Verzenio showed promising efficacy in high-grade meningiomas with CDK pathway or NF2 alterations, achieving progression-free survival at six months in 14 of 24 patients. Patients with NF2 alterations ...
While bigger funds may get the headlines, small-value funds have their own appeal. As Morningstar fund reporter Gabe Alpert explains, “The long-term outperformance of such stocks has been empirically ...
The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.
The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results